Critical factors in the translation of improved antimicrobial strategies for medical implants and devices

Biomaterials

Volumn 34, Issue 37, 2013, Pages 9237-9243

  Grainger, David W ^a,b   van der Mei, Henny C ^c   Jutte, Paul C ^c   van den Dungen, Jan J A M ^c   Schultz, Marcus J ^d   van der Laan, Bernard F A M ^c   Zaat, Sebastian A J ^d   Busscher, Henk J ^c  

^a UNIVERSITY OF UTAH   (United States)

^b Department of Electrical and Computer Engineering   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biomaterial associated infection; Clinical translation; Clinical trials; Hospital hygiene; Implant infection; Stakeholders

Indexed keywords

BIOMATERIAL-ASSOCIATED INFECTION; CLINICAL TRANSLATION; CLINICAL TRIAL; HOSPITAL HYGIENES; IMPLANT INFECTIONS; STAKEHOLDERS;

BIOMATERIALS; BIOMEDICAL EQUIPMENT; MICROORGANISMS; RISK PERCEPTION;

BIOLOGICAL MATERIALS;

ANTIBIOTIC AGENT; ANTIBIOTIC BONE CEMENT; C REACTIVE PROTEIN; CISPLATIN; GENTAMICIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; AORTA RUPTURE; ARTICLE; BIOMATERIAL ASSOCIATED INFECTION; BONE NAIL; BONE NAIL INFECTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CATHETER INFECTION; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COAGULASE POSITIVE STAPHYLOCOCCUS; COMPUTER ASSISTED TOMOGRAPHY; DEVICE APPROVAL; DEVICE INFECTION; DEVICE REMOVAL; EXTERNAL FIXATOR; FEMALE; FEVER; FRACTURE FIXATION; FRACTURE HEALING; GRAFT INFECTION; HUMAN; IMPLANT; INFECTION RATE; LARYNGECTOMY; LARYNX SQUAMOUS CELL CARCINOMA; LEG FRACTURE; LEUKOCYTE COUNT; MALE; MEDICAL DEVICE; MITRAL VALVE REGURGITATION; MOLECULAR TYPING; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OPERATION DURATION; ORTHOPEDIC IMPLANT; OSTEOMYELITIS; PACEMAKER; PRIORITY JOURNAL; PROSTHESIS LOOSENING; PROSTHETIC VALVE ENDOCARDITIS; PROTEIN BLOOD LEVEL; REOPERATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TOTAL HIP PROSTHESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT DURATION; VOICE PROSTHESIS; WOUND CARE; WOUND HEALING;

BIOMATERIAL-ASSOCIATED INFECTION; CLINICAL TRANSLATION; CLINICAL TRIALS; HOSPITAL HYGIENE; IMPLANT INFECTION; STAKEHOLDERS;

ADOLESCENT; AGED; ANTI-BACTERIAL AGENTS; AORTIC RUPTURE; ARTHROPLASTY, REPLACEMENT, HIP; BIOCOMPATIBLE MATERIALS; BLOOD VESSEL PROSTHESIS; BONE NAILS; ENDOCARDITIS; FEMALE; FRACTURES, BONE; HEART VALVE PROSTHESIS; HIP PROSTHESIS; HUMANS; LARYNX, ARTIFICIAL; LEG INJURIES; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; PROSTHESIS-RELATED INFECTIONS;

EID: 84884815688     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.08.043     Document Type: Article

References (19)

1. Ratner B.D., Hoffman A.S., Schoen F.J., Lemons J. Biomaterials science: an evolving, multidisciplinary endeavor. Biomaterials science 2012, xxv. Elsevier, Amsterdam. 3rd ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
2. Ratner B.D. Ahistory of biomaterials. Biomaterials science 2012, xli. Elsevier, Amsterdam. 3rd ed. B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons (Eds.).
3. Busscher H.J., Van der Mei H.C., Subbiahdoss G., Jutte P.C., Van den Dungen J.J.A.M., Zaat S.A.J., et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med 2012, 4(153):rv10.
4. Brooks B., Brooks A., Grainger D.W. Antimicrobial technologies in preclinical and clinical medical devices. Biomaterials associated infection: immunological aspects and antimicrobial strategies 2012, 307-354. Springer Verlag, New York. T.F. Moriarty, S.A.J. Zaat, H.J. Busscher (Eds.).
5. Dairouche R.O. Treatment of infections associated with surgical implants. NEngl J Med 2004, 350:1422-1429.
6. Zimmerli W., Trempuz A. Biomaterial associated infection: a perspective from the clinic. Biomaterials associated infection: immunological aspects and antimicrobial strategies 2012, 3-24. Springer Verlag, New York. T.F. Moriarty, S.A.J. Zaat, H.J. Busscher (Eds.).
7. Darouiche R.O. Antimicrobial-modified vascular catheters. Biomaterials associated infection: immunological aspects and antimicrobial strategies 2012, 485-504. Springer Verlag, New York. T.F. Moriarty, S.A.J. Zaat, H.J. Busscher (Eds.).
8. Kingshott P., Griesser H.J. Surfaces that resist bioadhesion. Curr Opin Solid State Mat Sci 1999, 4:403-412.
9. Darouiche R.O. Antimicrobial approaches for preventing infections associated with surgical implants. Clin Infect Dis 2003, 36:1284-1289.
10. Schmidmaier G., Gahukamble A.D., Moriarty T.F., Richards G.R. Infection in fracture fixation: device design and antibiotic coatings reduce infection rates. Biomaterials associated infection: immunological aspects and antimicrobial strategies 2012, 435-453. Springer Verlag, New York. T.F. Moriarty, S.A.J. Zaat, H.J. Busscher (Eds.).
11. Illingworth B.L., Tweden K., Schroeder, Camero J.D. Invivo efficacy of silver-coated (Silzone) infection-resistant polyester fabric against a biofilm-producing bacteria, Staphylococcus epidermidis. JHeart Valve Dis 1998, 7:524-530.
12. Darouiche R.O., Meade R., Mansouri M., Raad I.I. Invivo efficacy of antimicrobial-coated fabric from prosthetic heart valve sewing rings. JHeart Valve Dis 1998, 7:639-646.
13. Grunkemeier G.L., Jin R., Im K.A., Holubkov R., Kennard E.D., Schaff H.V. Time-related risk of the St. Jude Silzone heart valve. Eur J Cardiothorac Surg 2006, 30:20-27.
14. Grunkemeier G.L., Wu Y.-X. The Silzone effect: how to reconcile contradictory reports?. Eur J Cardiothorac Surg 2004, 253:371-375.
15. Englberger L., Schaff H.V., Jamieson W.R.E., Kennard E.D., Im K.A., Holubkov R., et al. Importance of implant technique on risk of major paravalvular leak (PVL) after St. Jude mechanical heart valve replacement: a report from the artificial valve endocarditis reduction trial (AVERT). Eur J Cardiothorac Surg 2005, 28:838-843.
16. Knobben B.A.S., Engelsma Y., Neut D., Van der Mei H.C., Busscher H.J., Van Horn J.R. Intraoperative contamination influences wound discharge and periprosthetic infection. Clin Orthop Relat Res 2006, 452:236-241.
17. Uckay I., Hoffmeyer P., Lew D., Pittet D. Prevention of surgical site infections in orthopaedic surgery and bone trauma: state-of-the-art update. JHosp Infect 2013, 84:5-12.
18. Rosenthal M.B. Nonpayment for performance? Medicare's new reimbursement rule. NEngl J Med 2007, 357:1573-1575.
19. Brown J., Doloresco F., Mylotte J.M. "Never events": not every hospital-acquired infection is preventable. Clin Infect Dis 2009, 49:743-746.